Free Trial

ALX Oncology (ALXO) SEC Filings & 10K Form

ALX Oncology logo
$1.33 -0.01 (-0.75%)
(As of 11/14/2024 ET)

Recent ALX Oncology SEC Filings

DateFilerForm TypeView
11/14/2024
6:22 PM
ALX Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
11/14/2024
5:58 PM
ALX Oncology (Subject)
Vivo Capital Fund IX, L.P. (Filed by)
Form SC 13G/A
11/14/2024
2:02 PM
ALX Oncology (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G/A
11/14/2024
7:03 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
3:14 PM
ALX Oncology (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
10/04/2024
8:00 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
3:00 PM
ALX Oncology (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
08/16/2024
4:05 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:06 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:08 PM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:09 PM
ALX Oncology (Issuer)
Randolph Sophia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:10 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:17 PM
ALX Oncology (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
08/07/2024
4:23 PM
ALX Oncology (Issuer)
Sandler Alan B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:22 PM
ALX Oncology (Issuer)
Sandler Alan B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2024
3:45 PM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
3:23 PM
ALX Oncology (Subject)
Pons Jaume (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:09 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:39 PM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
8:00 AM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4/A
06/17/2024
6:29 AM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:46 PM
ALX Oncology (Issuer)
Garland J. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:49 PM
ALX Oncology (Issuer)
Hemrajani Rekha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:42 PM
ALX Oncology (Issuer)
GOODMAN COREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:14 PM
ALX Oncology (Subject)
Pons Jaume (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
3:10 PM
ALX Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
4:31 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
3:49 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:34 PM
ALX Oncology (Subject)
Pons Jaume (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/05/2024
4:37 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:37 PM
ALX Oncology (Subject)
Pons Jaume (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
5:24 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:03 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:09 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:17 PM
ALX Oncology (Issuer)
Randolph Sophia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:21 PM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:45 PM
ALX Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/14/2024
6:28 PM
ALX Oncology (Subject)
LSV Associates, LLC (Filed by)
Form SC 13D/A
02/09/2024
7:35 AM
ALX Oncology (Subject)
FMR LLC (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALXO) was last updated on 11/15/2024 by MarketBeat.com Staff
From Our Partners